Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Mesenchymal stem cells
Randomized controlled single-blind trial 		Potential treatment - clinical evidence Experimental Other treatment Oct/17/2022
BNT162b2
Randomized controlled single-blind trial 		Approved by FDA Experimental Vaccine Jun/22/2022
Convalescent plasma
Randomized controlled single-blind trial 		Emergency use authorization Experimental Antiviral May/16/2022
ChAdOx1 nCoV-19
Randomized controlled single-blind trial 		Emergency use authorization Experimental Vaccine Jan/04/2022
Methylprednisolone
Randomized controlled single-blind trial 		Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/21/2021
Ritonavir
Randomized controlled single-blind trial 		Emergency use authorization Used to treat other disease Antiviral Nov/02/2021
Lopinavir
Randomized controlled single-blind trial 		Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/22/2021
NVX-CoV2373
Randomized controlled single-blind trial 		Potential treatment - clinical evidence Experimental Vaccine Apr/07/2021
Arbidol
Randomized controlled single-blind trial 		Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/03/2021
rSIFN-co
Randomized controlled single-blind trial 		Potential treatment - clinical evidence Experimental Antiviral Feb/23/2021
Vitamin D3
Randomized controlled single-blind trial 		Potential treatment - clinical evidence Used to treat other disease Other treatment Feb/17/2021
BNT162b1
Randomized controlled single-blind trial 		Potential treatment - clinical evidence Experimental Vaccine Aug/12/2020
Export (.csv)